IRCT20191217045769N1招募中未知
A comparative study on the effect of using nasal protector (Neo-Guard)on the incidence rate and severity of nasal injury in preterm infants treated with Nasal-Continuous Positive Airway Pressure
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 8 months（—）
- 性别
- All
入选标准
- •Premature infants 32 weeks or less or premature infants weighing 1500 g or less who require N-CPAP
- •Parents are satisfied with the baby's entry into the study.
排除标准
- •Premature infants who are >32 weeks of postmenstrual age (PMA) or Premature infants(<37 weeks(PMA)) at a weight <1500 g
- •The infant was intubated before receiving N-CPAP and received invasive ventilation
- •Preterm infants who had facial features that might preclude treatment with binasal CPAP (eg, cleft lip, Pierre Robin sequence,choanal atresia)
研究者
相似试验
已完成
不适用
A comparison of the effect of Nasal Continuous Positive Airway Pressure (NCPAP) vs Nasal high-frequency oscillation(NHFO) in the treatment of respiratory distress in preterm infantsIRCT20201222049795N1Semnan University of Medical Sciences20
已完成
不适用
Comparison of the effectiveness of nasal continuous positive airway pressure (NCPAP) therapy with combination of High-Frequency Oscillations and NCPAP in treatment of respiratory distress syndrome in infantsRespiratory distress syndrome.Respiratory distress syndrome of newbornP22.0IRCT20180915041040N3Shahre-kord University of Medical Sciences40
招募中
不适用
Evaluation of the Use of Antiseptic Nose For Decolonization of Resistant Bacteria in HospitalsHuman patients infectedMethicillin-resistant Staphylococcus aureus.B03.300.390.400.800.750.100.500RBR-6gs2jhFaculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
已完成
不适用
study for the quantitative assessment of the nasal pathway as compared to combined oro-nasal pathway in terms of expired tidal volume when patient is ventilated via face mask under general anaesthesia.CTRI/2019/02/017777Maulana Azad Medical college40
已完成
2 期
euroEPO in patients with Mild-Moderate Alzheimer's diseaseMild to moderate Alzheimer'sAlzheimer DiseaseBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersDementiaRPCEC00000232Center of Molecular Immunology (CIM)174